MeiraGTx Buys Back Eye Gene Therapy from J&J
MeiraGTx Regains Eye Drug Rights from J&J
Ocugen CEO Pushes Gene Therapy to the Masses
PYC Therapeutics advances eye disease drug trials update
Treatment
Foods To Avoid
Latest
MeiraGTx Reacquires Eye Gene Therapy from J&J After Clinical Setback In the high-stakes world of…
MeiraGTx Reclaims Genetic Eye Disease Drug Rights From Johnson & Johnson In a significant shift…
Ocugen Aims for Three Gene Therapy Approvals to Democratize Treatment For decades, gene therapy has…
PYC Therapeutics Advances Blinding Eye Disease Drug Trials: A New Dawn for Patients For the…
Protect Your Vision: 5 Daily Habits That Harm Your Eye Health We often think of…
Lab-Grown Retina Reveals Genetic Cause of Rare Childhood Eye Disease For families navigating the difficult…
A Young Hunter’s Dream: Bagging a Gobbler with a Rare Eye Disease The crisp morning…
Lab-Grown Retina Uncovers Gene Clue for Rare Childhood Eye Disease For families navigating the complexities…





